| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| BIENAIME JEAN JACQUES | Director | C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL | /s/ Sandra Stoneman, Attorney-in-Fact | 03 Jun 2025 | 0001221590 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IMNM | Common Stock | Purchase | $46,900 | +5,000 | +16% | $9.38 | 36,415 | 03 Jun 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The weighted average purchase price for the transaction report was $9.38, and the range of prices were between $9.36 and $9.40, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |